Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alliant Preps For Orapred ODT Launch With Increased Sales Force

This article was originally published in The Pink Sheet Daily

Executive Summary

Wholesale acquisition cost for the prednisolone tablets will be similar to existing oral solution at $119.50 for 48 tablets.

You may also be interested in...



Orapred Website Taken Down After FDA Warning; Corrected Site Will Return

BioMarin’s website for the oral corticosteroid underplayed risk, broadened its indication and made unsubstantiated claims, DDMAC says.

Orapred Website Taken Down After FDA Warning; Corrected Site Will Return

BioMarin’s website for the oral corticosteroid underplayed risk, broadened its indication and made unsubstantiated claims, DDMAC says.

Orapred Tablet Formulation Gets FDA Nod

BioMarin corticosteroid asthma treatment will be marketed by Alliant in North America.

Topics

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel